companies / ascentbionano-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-05 json
| total_raised | 2,204,4162.2M | ○ |
|---|---|---|
| founded | 2017 | |
| hq | Morrisville, North Carolina, USA | |
| industry | unknown | |
| stage | null |
Develops acoustic microfluidic platforms that isolate and analyze rare cells and biomarkers from blood and biofluids. Sold to clinical-research and diagnostics partners working on rare-cell-based assays and translational oncology. Acoustic separation handles fragile cells without antibody capture, opening assays incompatible with magnetic-bead workflows.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2024-06-01 | grant | 2,200,0002.2M | null | ○ |
All in One SEO 4.2.7.1, Apache HTTP Server, Google Analytics, Google Tag Manager, jQuery Migrate 3.4.1, DoubleClick Floodlight, Contact Form 7 5.6.4, PHP, MySQL, wordpress 6.8.5, jquery 3.7.1, apache
| fact | status | src |
|---|---|---|
| Grant, $2.2M | attributed | ○ |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-17provenance_existence: self-reported → sourced, WEB 2026-10-17 | provenance_existence | self-reported → sourced | WEB 2026-10-17 |
Records begin 2026-09-24. all_changes